Scinai Immunotherapeutics (SCNI) Non-Current Assets (2017 - 2026)

Scinai Immunotherapeutics (SCNI) posted Non-Current Assets of $14.0 billion for Q1 2026, up 45.99% sequentially from $9.6 billion in Q4 2025.

Scinai Immunotherapeutics (SCNI) Non-Current Assets (2017 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Non-Current Assets for 10 years, with the latest figure at $14.0 billion in Q1 2026.

Quarterly Non-Current Assets changed N/A year-over-year to $14.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.0 billion (changed N/A YoY) and the FY2025 annual result came in at $9.6 billion, up 86469.59% from the prior year.
Non-Current Assets grew to $14.0 billion in Q1 2026 per SCNI's latest filing, from $9.6 billion in the prior quarter.
Over five years, Non-Current Assets peaked at $14.0 billion in Q1 2026 and troughed at $10.3 million in Q2 2025.
A 5-year average of $1.7 billion and a median of $12.1 million in 2023 frame the typical range for Non-Current Assets.
The sharpest annual moves came in 2022 and 2025: Non-Current Assets declined 10.54% in 2022, then soared 86469.59% in 2025.
Over 5 years, Non-Current Assets stood at $12.7 million in 2022, then fell by 5.29% to $12.0 million in 2023, then retreated by 8.05% to $11.1 million in 2024, then jumped by 86469.59% to $9.6 billion in 2025, then jumped by 45.99% to $14.0 billion in 2026.
According to Business Quant data, Non-Current Assets over the past three periods registered $14.0 billion, $9.6 billion, and $10.3 million for Q1 2026, Q4 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	14.88 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	23.28 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	1.96 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	5.15 Bn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	1.96 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	938.60 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	6.80 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	468.65 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	18.06 Bn
10	Scinai Immunotherapeutics	11.72 Mn	-3.10 Bn	-1.12 Mn	13.97 Bn

Download Data